Regenerative Medical Technology Group Inc.

Q: Jun 30 2026

Q: Jun 30 2026

Q: Mar 31 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

Q: Mar 31 2024

FY: Dec 31 2023

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

8.01

2.02,9.01

1.01,3.02,9.01

4.01,9.01

Entry into a Material Definitive Agreement

4.01,9.01

1.01,2.01,3.02,5.01,5.02,8.01,9.01

1.01,3.02,3.03,5.02,5.03,7.01,9.01

1.01,3.03,9.01

Entry into a Material Definitive Agreement

5.01,5.02

8.01

1.01,3.03,9.01

8.01

1.01,3.03,9.01

1.01,3.02,3.03,5.02,5.03,7.01,9.01

8.01,9.01

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notice of Effectiveness

Post-effective amendment to a registration statement

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

No description available

No description available

No description available

No description available

No description available

No description available

Novas Benito

Christensen David Eugene

Christensen David Eugene

none

Pereira Melvin Antonio Loria

Definitive information statement

Definitive information statement

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC